维普中文期刊产品整合服务

Protective effects of pharmacological therapies in animal models of multiple sclerosis: a review of studies 2014–2019

查看全文 作　　者：Bridget [1,2]Martinez;Philip [3]V.Peplow 高影响力作者 机构地区：[1]Physical Chemistry and Applied Spectroscopy,Chemistry Division,Los Alamos National Laboratory,Los Alamos,NM,USA;[2]Department of Medicine,St.Georges University School of Medicine,True Blue,Grenada;[3]Department of Anatomy,University of Otago,Dunedin,New Zealand高影响力机构 出　　处：《Neural Regeneration Research》索引2020年第15卷第7期,共15页高影响力期刊 摘　　要：Multiple sclerosis(MS)is an inflammatory demyelinating disease of the central nervous system.The disability caused by inflammatory demyelination clinically dominates the early stages of relapsing-remitting MS and is reversible.Once there is considerable loss of axons,MS patients enter a secondary progressive stage.Disease-modifying drugs currently in use for MS suppress the immune system and reduce relapse rates but are not effective in the progressive stage.Various animal models of MS(mostly mouse and rat)have been established and proved useful in studying the disease process and response to therapy.The experimental autoimmune encephalomyelitis animal studies reviewed here showed that a chronic progressive disease can be induced by immunization with appropriate amounts of myelin oligodendrocyte glycoprotein together with mycobacterium tuberculosis and pertussis toxin in Freund's adjuvant.The clinical manifestations of autoimmune encephalomyelitis disease were prevented or reduced by treatment with certain pharmacological agents given prior to,at,or after peak disease,and the agents had protective effects as shown by inhibiting demyelination and damage to neurons,axons and oligodendrocytes.In the cuprizone-induced toxicity animal studies,the pharmacological agents tested were able to promote remyelination and increase the number of oligodendrocytes when administered therapeutically or prophylactically.A monoclonal IgM antibody protected axons in the spinal cord and preserved motor function in animals inoculated with Theiler's murine encephalomyelitis virus.In all these studies the pharmacological agents were administered singly.A combination therapy may be more effective,especially using agents that target neuroinflammation and neurodegeneration,as they may exert synergistic actions. 关 键 词：animal models autoimmune encephalomyelitis disease cuprizone-induced toxicity multiple sclerosis NEURODEGENERATION NEUROINFLAMMATION neuroprotection pharmacological agents progressive disease Theiler's murine encephalomyelitis virus
相关文献

参考文献(76)

引证文献(5)

耦合文献(5)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费